Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials

Clinical Microbiology and Infection, 04/18/2012

Randomized controlled trials show an advantage of quinolones in the treatment of CAP with regard to clinical cure without need for antibiotic modification at end of treatment and gastrointestinal adverse events. The clinical significance of this advantage is unclear.

Print Article Summary Cat 2 CME Report